share_log

Canopy Growth | 424B3: Prospectus

Canopy Growth | 424B3: Prospectus

Canopy Growth | 424B3：募资说明书
美股sec公告 ·  05/13 17:34
Moomoo AI 已提取核心信息
Canopy Growth Corporation has filed a prospectus supplement on May 13, 2024, to update and supplement information in its previous prospectus dated May 13, 2024, with new details from its Current Report on Form 8-K. The supplement pertains to the offering and sale of 1,086,279 common shares by selling securityholders, which were issued on April 30, 2024, following amendments to initial option agreements related to the acquisition of Wana Wellness and other entities. The amendments include a reduction in the exercise price for the Wana Option and the issuance of common shares worth US$10,667,259.78. Additionally, Canopy Growth has entered into an eighth amendment to the Floating Share Arrangement Agreement with Canopy USA, LLC and Acreage Holdings, Inc., extending the Exercise Outside Date and the date for exercising...Show More
Canopy Growth Corporation has filed a prospectus supplement on May 13, 2024, to update and supplement information in its previous prospectus dated May 13, 2024, with new details from its Current Report on Form 8-K. The supplement pertains to the offering and sale of 1,086,279 common shares by selling securityholders, which were issued on April 30, 2024, following amendments to initial option agreements related to the acquisition of Wana Wellness and other entities. The amendments include a reduction in the exercise price for the Wana Option and the issuance of common shares worth US$10,667,259.78. Additionally, Canopy Growth has entered into an eighth amendment to the Floating Share Arrangement Agreement with Canopy USA, LLC and Acreage Holdings, Inc., extending the Exercise Outside Date and the date for exercising the Canopy Call Option to June 17, 2024. The completion of the Floating Share Arrangement is subject to certain conditions, and there is no certainty that the acquisition of Acreage will be completed. Canopy Growth's common shares are traded on the Toronto Stock Exchange and the Nasdaq Global Select Market under the symbols 'WEED' and 'CGC' respectively.
Canopy Growth Corporation已于2024年5月13日提交了招股说明书补充文件，以更新和补充其先前于2024年5月13日发布的招股说明书中的信息，其中新细节来自其表8-K的当前报告。该补充文件涉及通过出售证券持有人发行和出售1,086,279股普通股，该股票是在修订与收购Wana Wellness和其他实体相关的初始期权协议之后，于2024年4月30日发行的。修正案包括降低Wana期权的行使价以及发行价值10,667,259.78美元的普通股。此外，Canopy Growth已与Canopy USA, LLC和Acreage Holdings, Inc.签订了浮动股份安排协...展开全部
Canopy Growth Corporation已于2024年5月13日提交了招股说明书补充文件，以更新和补充其先前于2024年5月13日发布的招股说明书中的信息，其中新细节来自其表8-K的当前报告。该补充文件涉及通过出售证券持有人发行和出售1,086,279股普通股，该股票是在修订与收购Wana Wellness和其他实体相关的初始期权协议之后，于2024年4月30日发行的。修正案包括降低Wana期权的行使价以及发行价值10,667,259.78美元的普通股。此外，Canopy Growth已与Canopy USA, LLC和Acreage Holdings, Inc.签订了浮动股份安排协议的第八次修正案，将行使日期和行使Canopy看涨期权的日期延长至2024年6月17日。浮动股份安排的完成受某些条件的约束，而且不确定对Acreage的收购是否会完成。Canopy Growth的普通股分别在多伦多证券交易所和纳斯达克全球精选市场上市，股票代码分别为 “WEED” 和 “CGC”。

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息